-
08/01/2009
Ablynx strengthens management team with the appointment of Dr Debbie Law as Chief Scientific Officer
-
09/01/2009
CoreValve Prevails in United Kingdom Patent Infringement Action
-
13/01/2009
Inside Contactless Named “Red Herring 100 Global” Finalist
-
13/01/2009
Thomas Gebauer joins ReVolt Technology, Ltd as CFO
-
14/01/2009
Ablynx announces technical advances in its NANOBODY® platform technology: enhanced benefits from pulmonary delivery and half-life extension
-
15/01/2009
ReVolt Technology, Ltd Receives Additional 10 Million Euro B Round Investment
-
16/01/2009
Purple Labs Closes 52 Million Euro License And Development Agreement Following Acquisition Of Sagem Mobile Software
-
20/01/2009
ReVolt Technology, Ltd Forms Technical Advisory Board
-
21/01/2009
Ablynx expands its musculoskeletal portfolio by taking P&G pharmaceuticals' programme in-house
-
21/01/2009
Vivalis and Innate Pharma sign a collaboration and commercial license agreement to develop Innate's novel monoclonal antibody, to be manufactured with vivalis'EB66® platform, for rare cutaneous cancers
-
21/01/2009
DBV Technologies raises €6 million (EUR) in Series B investment and secures new corporate investor
-
21/01/2009
Vivalis et Innate Pharma signent un accord de collaboration et de licence commerciale pour le développement d'un nouvel anticorps d'Innate produit sur la plateforme EB66® pour le traitement de cancers cutanés rares
-
22/01/2009
Emailvision, 1er éditeur international des logiciels «SaaS» pour la gestion et l’optimisation des campagnes d’e-mail marketing, publie son chiffre d’affaires 2008.
-
28/01/2009
Addex Successfully Completes ADX48621 Phase I Program
-
28/01/2009
PC 30 - journal télévisé France 2 - 26 déc
-
04/02/2009
Inside Contactless and Sagem Wireless extend NFC Technology Partnership
-
05/02/2009
String of Achievements Reinforces Company’s Leadership Role
-
11/02/2009
NFC Technology Part of Qualcomm 3G Handset Reference Designs,
-
13/02/2009
Esmertec to acquire Purple Labs creating Europe’s largest mobile phone software company
-
23/02/2009
Sofinnova Partners realizes impressive exit with sale of portfolio company CoreValve to Medtronic
-
23/02/2009
Sofinnova Partners réussit la sortie de CoreValve : vente à Medtronic pour un montant initial de 700 millions de dollars
-
17/02/2009
Tech tour seeks 'Best of French' emerging technology companies
-
05/03/2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
-
05/03/2009
GlycoVaxyn AG lève CHF 25 Million d’argent frais
-
03/03/2009
Novexel’s NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients with complicated Intra- Abdominal Infections (cIAIs)
-
03/03/2009
Novexel débute une deuxième étude clinique de phase II sur l’association NXL104/ceftazidime chez des patients hospitalisés atteints d’infections intra-abdominales compliquées
-
10/03/2009
EOS (Ethical Oncology Science) Closes an € 8.2 Million (US$ 10 Million) Series A Financing to Advance Innovative Targeted Cancer Therapies
-
12/03/2009
Acute myocardial infarction (AMI) successfully treated with Stentys self-expanding platform,solving stent-malapposition
-
17/03/2009
PC30 annonce le rachat de la société SMARTFIX aux Pays-Bas
-
25/03/2009
Sofinnova Partners Voted 2008 “European Venture Capital Firm of the Year”
-
25/03/2009
Sofinnova Partners élu « Société de capital-risque européenne de l'année 2008 »
-
30/03/2009
Ablynx reports detailed positive phase Ib results for its anti-thrombotic Nanobody® ALX-0081
-
31/03/2009
First Data and Inside Contactless launch partnership for go-tag payment sticker technology
-
02/04/2009
Paris, le 2 avril 2009 - PC30 | Comptes 2008
-
08/04/2009
PC30 - Challenges
-
15/04/2009
Travel technology leader Sprice.com to power Sify's travel search
-
20/04/2009
UPEK and WinMagic Announce Biometric Authentication and Hard Disk Encryption Solution for SMBs Eikon Fingerprint Reader ...
-
13/04/2009
PC 30 | ITÉLÉ 13 AVRIL 09 20H30-21H - Vive les entreprises de service ?
-
21/04/2009
Neosens closes a second funding round of €4M
-
27/04/2009
Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy
-
27/04/2009
Innate Pharma nomme le Docteur Rozencweig au poste de Senior Vice Président, stratégie clinique et réglementaire
-
29/04/2009
LITTLETON, Colorado, April 29, 2009 – CPI Card Group (CPI), a global leader in financial and commercial card production and services, and INSIDE Contactless, a leading provider of advanced, open-standard contactless chip technologies, today announced they
-
07/05/2009
Ablynx announces that its VWF NANOBODY® programme has been granted orphan drug designation and provides a business update for the first quarter 2009
-
11/05/2009
HRA pharma and Preglem announce successful completion of phase IIB for ulipristal acetate for the treatment of uterine fibroids
-
15/05/2009
UPEK Wins TiE50 Award
-
27/05/2009
U.S. Bank first to offer a single visa card for identification, purchases and secure facility access
-
28/05/2009
Inside debuts converged contactless payment/access control platform
-
30/05/2009
Innate Pharma reports preliminary phase I clinical data for IPH 2101 (a novel, anti-kir monoclonal antibody activating NK celles) at the ASCO meeting
-
02/06/2009
Consumers “Tap” Over One Million Mobile Searches Daily
-
28/05/2009
HID Global Together with INSIDE Contactless Debut Converged Platform for Access Control and Payment Solutions
-
02/06/2009
Myriad Group AG announces Q1 revenue of USD 30 million
-
02/06/2009
UPEK Unveils Fingerprint Sensor with Integrated LEDs
-
08/06/2009
NOXXON Announces Initiation of First Clinical Trial with a Spiegelmer®
-
19/06/2009
ReVolt Technology Selected as a Top-24 European Cleantech Leader
-
18/06/2009
Sprice.Com Teams Up With AsiaOne
-
22/06/2009
blueKiwi lève 3 millions d'euros auprès de Dassault Systèmes
-
23/06/2009
Takeda Establishes "Takeda Global Advisory Board"
-
22/06/2009
Sofinnova Partners Leads Investment Round in CoAxia
-
26/06/2009
Ablynx wins european mediscience award for best technology
-
29/06/2009
Innate Pharma reports positive phase IIa clinical results for IPH 1101 (ãä T CELL AGONIST) in type C viral hepatitis
-
29/06/2009
Innate Pharma annonce des r¨¦sultats de phase IIa positifs avec IPH 1101 (agonistedes lymphocytes T ¦Ã¦Ä) dans l'h¨¦patite virale de type C
-
02/07/2009
PC30 reprend les activités « desktop » de SOGETI en Ile de France
-
02/07/2009
Ablynx promoted to the belgian MID-CAP-INDEX
-
06/07/2009
Blue Kiwi | The Europas Shortlist: Best Enterprise / B2B Startup
-
08/07/2009
Stentys receives CE Mark approval
-
09/07/2009
ReVolt Technology, Ltd & BASF Announce Joint Development Agreement for Rechargeable Zinc-Air Battery
-
09/07/2009
Maurice Petitou, Directeur de la Recherche chez Endotis Pharma, Lauréat du Prix Charles Mentzer pour ses découvertes et le développement d’oligosaccharides de synthèses dans la maladie thromboembolique
-
09/07/2009
Maurice Petitou, Head of Preclinical Research & Development at Endotis Pharma, wins the Charles Mentzer Prize for his discoveries on synthetic oligosaccharides in thrombosis
-
15/07/2009
INTERAC® Partners with Global Leader INSIDE to bring Contactless Debit to Canada
-
27/07/2009
Movetis receives positive opinion by the CHMP on European Marketing Authorisation Application for Resolor® (prucalopride) indicated for the treatment of Chronic Constipation
-
27/07/2009
Orange to offer free gifts to students who agree to receive ads on mobiles
-
21/07/2009
Multek Enhances Touch Screen Solution Through Sensitive Object Strategic Alliance
-
30/07/2009
EOS (Ethical Oncology Science) Closes Series A Financing with new Investor AESCAP Venture joining Sofinnova Partners and Quantica SGR
-
30/07/2009
Renforcement du conseil de surveillance de PC30 Jean Marie Descarpentries nommé Président
-
13/08/2009
Inside Contactless and cryptography research sign agreement to license DPA patents
-
12/08/2009
Upek launches developer contest for Windows 7 Biometric applications
-
12/08/2009
Richard L. Middaugh Joins ReVolt Technology Advisory Board
-
18/08/2009
Orexo announces that its partner Meda has initiated the launch of EdluarTM in the USA
-
18/08/2009
Ablynx announces positive Phase I results for subcutaneous administration of its ANTI-THROMBOTIC NANOBODY® (ALX-0681)
-
18/08/2009
Myriad Delivers Services Platform for Customer Service to T-Mobile
-
27/08/2009
Ablynx announces half-year results for 2009
-
28/08/2009
Orexo signs exclusive worldwide license agreement for a novel formulation
-
27/08/2009
Start of the first phase II clinical trial with monoclonal antibody IPH 2101 supported by a new 2.9 millions euros financing from OSEO
-
28/08/2009
Stentys appoints Vice President of Sales and Marketing
-
01/09/2009
ReVolt Technology Applies for $30 million in Government Research Grants Accelerating Development of Innovative Zinc-Air Batteries for Vehicles and Renewable Energy Storage Company selects Portland, Oregon as location for US HQ & R&D Center
-
01/09/2009
Ablynx inititates Phase II clinical trial for ALX-0081
-
03/09/2009
NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer® NOX-A12
-
01/09/2009
Myriad Appoints James Bodha as New Chief Financial Officer
-
08/09/2009
Inside Contactless and Connecthings team to take NFC to the next level
-
09/09/2009
ReVolt Technology named a Global Cleantech 100 clean technology company
-
09/09/2009
Neosens named a Global Cleantech 100
-
10/09/2009
SFR a sélectionné WYPLAY pour sa prochaine génération de décodeurs TV
-
10/09/2009
SFR selects WYPLAY for its next generation of HD IP-STB
-
09/09/2009
Engel and Wyplay parnter for next generation connected HD STB
-
11/09/2009
Myriad Introduces World’s First Widget Solution for Ultra-Low Cost Mobile Phones
-
14/09/2009
Stentys to disclose results of 'APPOSITION I' clinical study, world's first to treat acute myocardial infarction (AMI) with a self-expanding stent
-
14/09/2009
Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
-
15/09/2009
Myriad Group Acquires Xumii, Inc.
-
22/09/2009
Myriad Appoints Former Nokia Chief Technologist Benoit Schillings as Chief Technical Officer
-
22/09/2009
UPEK Expands Biometric Market with Launch of New TouchChip® Fingerprint Solutions
-
23/09/2009
Myriad Group Reports EBITDA of USD 11 Million for 2009 H1
-
28/09/2009
Addex complète le recrutement d’un premiere essai clinique intermédiare sur le RGO
-
28/09/2009
Addex completes enrollment of first mid-stage clinical GERD trial
-
28/09/2009
Upek launches new product line optimized for mobile phone applications
-
01/10/2009
CONNECTHINGS, INSIDE Contactless and Sagem Wireless Receive Grant from French Government for First Wave-Me Services
-
01/10/2009
Sofinnova Partners annonce un accord portant sur la cession de Fovea Pharmaceuticals à Sanofi Aventis
-
01/10/2009
Sofinnova Partners announces an agreement to sell Fovea Pharmaceuticals to Sanofi Aventis
-
01/10/2009
Ablynx receives milestone payment as part of its strategic alliance with Boehringer Ingelheim
-
06/10/2009
PUMA partners with Sagem Wireless to launch PUMA Mobile Phone
-
06/10/2009
Orexo confirms FDA acceptance of Abstral filing
-
12/10/2009
Crescendo Biologics Raises £4.5 million in Seed-Funding Led by Sofinnova Partners
-
12/10/2009
NOXXON Pharma AG announces excellent preliminary phase I trial results for Spiegelmer® NOX-E36 - good safety and pharmacodynamic profile and additional good subcutaneous bioavailability
-
12/10/2009
Ablynx and Domantis settle their dispute and stop the arbitration process
-
15/10/2009
Protector Suite 2009 Software Adds Support for Windows 7 and the Windows Biometric Framework
-
15/10/2009
MicroPass 5100 “ICAO Lite” Products Compete for Best Identification Solution
-
15/10/2009
Accent - Itron Selects Accent Single Chip Solution for Smart Metering Applications
-
16/10/2009
Flexion Therapeutics Raises $33 Million in Series A Financing
-
19/10/2009
Endotis Pharma has initiated a Phase I program with the neutralizable anticoagulant EP217609 and its specific antidote avidin, and signed a manufacturing and co-development agreement with Sigma-Tau for avidin
-
21/10/2009
Largest Retail Deployment of Contactless Loyalty Sticker Technology in France
-
22/10/2009
Movetis obtains EU authorisation for the commercialisation of Resolor® (prucalopride). First launch of Resolor anticipated in Q1 2010.
-
23/10/2009
Le cabinet d'analystes Gartner vient de classer blueKiwi Software comme entreprise "Visionnaire" dans son Magic Quadrant 2010 sur les Réseaux Sociaux d'Entreprise ("Social Software in the Workplace 2010")
-
26/10/2009
Sofinnova Partners Leads $12 Million Series A Round in DNP Green Technology
-
26/10/2009
Sofinnova Partners, principal investisseur dans la première levée de fonds de 12 millions de dollars de DNP Green Technology
-
27/10/2009
Stentys expands Scientific Advisory Board (SAB) on heels of reporting successful clinical trial results for world's first self-expanding stent to treat AMI
-
27/10/2009
Sagem Wireless collaborates with CRYSTALLIZED™ – Swarovski Elements
-
03/11/2009
Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
-
03/11/2009
Inside Contactless open Asia testing facility
-
02/11/2009
NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer® NOX-A12
-
02/11/2009
Chiffre d’affaires 3ème trimestre 2009
-
16/11/2009
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
-
18/11/2009
Ablynx achieves third milestone in drug discovery and development collaboration
-
17/11/2009
UPEK Announces EikonTouch™ USB Fingerprint Readers
-
19/11/2009
INSIDE Contactless wins in Semiconductor, Electronic and Components Category
-
03/12/2009
Movetis raises targeted €85 million in successful Initial Public Offering on Euronext Brussels
-
04/12/2009
First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)
-
03/12/2009
NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company
-
03/12/2009
Ablynx will receive further milestone payments of €3 million as part of its strategic alliance with Boehringer Ingelheim
-
03/12/2009
Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.
-
08/12/2009
mydeco.com Hires Ex-Google Product Manager
-
04/12/2009
Endotis Pharma presents Phase I clinical trials results for EP42675, a first-inclass synthetic parenteral anticoagulant, at the 51st Annual Meeting of the American Society of Hematology
-
02/11/2009
Endotis Pharma forms a strategic alliance with Catalent Pharma Solutions for the development of oral formulations of synthetic oligosaccharides and initiates preclinical development of EP37151, a first in-class oral anticoagulant
-
14/12/2009
Ablynx initiates Phase I for ALX-0141 (ANTI-RANKL)
-
14/12/2009
Addex ends migraine prevention study Conference call tomorrow at 2pm CET (8am ET)
-
23/12/2009
Sofinnova Partners annonce sa troisième cession de plus de 500 millions de dollars pour l’année 2009
-
23/12/2009
Novexel to be acquired by AstraZeneca
-
26/11/2009
MasterCard Canada Brings PayPass™ Payments to BlackBerry Smartphones
-
23/12/2009
Sofinnova Partners Announces for the Third Time in 2009 a Trade Sale over 500 million dollars
-
23/12/2009
Movetis raises a total of €97.75m via an additional €12.75 million Over-allotment Option
-
22/12/2009
Ablynx demonstrates proof-of-concept by biomarker for its anti-thrombotic ALX-0081
